Abstract

BackgroundFear of cancer recurrence (FCR) is common amongst cancer survivors. There is rapidly growing research interest in FCR but a need to prioritize research to address the most pressing clinical issues and reduce duplication and fragmentation of effort. This study aimed to establish international consensus among clinical and academic FCR experts regarding priorities for FCR research.MethodsMembers of the International Psycho-oncology Society (IPOS) Fear of Cancer Recurrence Special Interest Group (FORwards) were invited to participate in an online Delphi study. Research domains identified in Round 1 were presented and discussed at a focus group (Round 2) to consolidate the domains and items prior to presentation in further survey rounds (Round 3) aimed at gaining consensus on research priorities of international significance.ResultsThirty four research items were identified in Round 1 and 33 of the items were consolidated into six overarching themes through a focus group discussion with FCR experts. The 33 research items were presented in subsequent rounds of the delphi technique. Twenty one participants contributed to delphi round 1, 16 in round 2, and 25 and 29 participants for subsequent delphi rounds. Consensus was reached for 27 items in round 3.1. A further four research items were identified by panelists and included in round 3.2. After round 3.2, 35 individual research items were ratified by the panelists. Given the high levels of consensus and stability between rounds, no further rounds were conducted. Overall intervention research was considered the most important focus for FCR research. Panelists identified models of care that facilitate greater access to FCR treatment and evaluation of the effectiveness of FCR interventions in real world settings as the two research items of highest priority. Defining the mechanisms of action and active components across FCR/P interventions was the third highest priority identified.ConclusionThe findings of this study outline a research agenda for international FCR research. Intervention research to identify models of care that increase access to treatment are based on a flexible approach based on symptom severity and can be delivered within routine clinical care were identified as research areas to prioritize. Greater understanding of the active components and mechanisms of action of existing FCR interventions will facilitate increased tailoring of interventions to meet patient need.

Highlights

  • Diagnosis and improved treatments for cancer have led to higher survival rates (Arnold et al, 2019)

  • The survey results were presented and discussed at a focus group (Round 2) to consolidate the domains identified in round 1 prior to presentation in further survey rounds aimed at gaining consensus on research priorities of international significance to guide future collaborative research

  • Through the use of Delphi methods, this study developed consensus among key clinical and research stakeholders regarding aspects of Fear of Cancer Recurrence (FCR) research that should be prioritized in future international collaborations

Read more

Summary

Introduction

Diagnosis and improved treatments for cancer have led to higher survival rates (Arnold et al, 2019). There are increasing numbers of people living with the fear that their cancer will recur (Koch et al, 2013). New treatments have led to increased numbers of people with advanced disease living with uncertainty (Thewes et al, 2017). While some degree of fear of recurrence (FCR) defined as “fear, worry, or concern relating to the possibility that cancer will come back or progress” (Lebel et al, 2016)(pg3267) is considered normal, nearly 50% of survivors experience moderate to high levels, suggestive of clinical FCR. High levels of FCR can persist over time (Crist and Grunfeld, 2013) and negatively impact psychological wellbeing and quality of life, resulting in increased utilization of healthcare resources (Lebel et al, 2013; Simard et al, 2013; Thewes et al, 2013). This study aimed to establish international consensus among clinical and academic FCR experts regarding priorities for FCR research

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call